[go: up one dir, main page]

BRPI0819957A2 - "composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma" - Google Patents

"composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma"

Info

Publication number
BRPI0819957A2
BRPI0819957A2 BRPI0819957A BRPI0819957A BRPI0819957A2 BR PI0819957 A2 BRPI0819957 A2 BR PI0819957A2 BR PI0819957 A BRPI0819957 A BR PI0819957A BR PI0819957 A BRPI0819957 A BR PI0819957A BR PI0819957 A2 BRPI0819957 A2 BR PI0819957A2
Authority
BR
Brazil
Prior art keywords
preparing
stable
pharmaceutical composition
bupropion hydrochloride
sustained pharmaceutical
Prior art date
Application number
BRPI0819957A
Other languages
English (en)
Inventor
Fanda Anuj Kumar
Mukherji Gour
Panchal Maulik Kiritkumar
Original Assignee
Jubilant Organosys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jubilant Organosys Ltd filed Critical Jubilant Organosys Ltd
Publication of BRPI0819957A2 publication Critical patent/BRPI0819957A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0819957A 2008-01-14 2008-11-19 "composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma" BRPI0819957A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN117DE2008 2008-01-14
PCT/IN2008/000777 WO2009090670A2 (en) 2008-01-14 2008-11-19 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same

Publications (1)

Publication Number Publication Date
BRPI0819957A2 true BRPI0819957A2 (pt) 2015-09-15

Family

ID=54291754

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819957A BRPI0819957A2 (pt) 2008-01-14 2008-11-19 "composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma"

Country Status (10)

Country Link
US (1) US20100291225A1 (pt)
EP (1) EP2229053A4 (pt)
KR (1) KR20100107044A (pt)
AU (1) AU2008347949A1 (pt)
BR (1) BRPI0819957A2 (pt)
CA (1) CA2713365A1 (pt)
MX (1) MX2010007672A (pt)
RU (1) RU2010133982A (pt)
WO (1) WO2009090670A2 (pt)
ZA (1) ZA201004830B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12194006B2 (en) 2013-11-05 2025-01-14 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US12109178B2 (en) 2013-11-05 2024-10-08 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11433067B2 (en) 2013-11-05 2022-09-06 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11534414B2 (en) 2013-11-05 2022-12-27 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11969421B2 (en) 2013-11-05 2024-04-30 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) * 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
US12433884B2 (en) 2020-06-05 2025-10-07 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
US12472156B2 (en) 2020-06-05 2025-11-18 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
KR102536511B1 (ko) * 2020-06-25 2023-05-26 (주) 넥스팜코리아 날트렉손 서방형 매트릭스 제제와 부프로피온 서방형 매트릭스 제제의 단층정 복합제제와 그 제조 방법
WO2022119981A1 (en) 2020-12-01 2022-06-09 Antecip Bioventures Ii Llc Bupropion and dextromethrophan for reduction of suicide risk in depression patients
US11717518B1 (en) 2022-06-30 2023-08-08 Antecip Bioventures Ii Llc Bupropion dosage forms with reduced food and alcohol dosing effects
US12156914B2 (en) 2022-06-30 2024-12-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising bupropion and cysteine
US20240000729A1 (en) * 2022-06-30 2024-01-04 Axsome Therapeutics, Inc. Microparticles containing bupropion
US12036191B1 (en) 2022-06-30 2024-07-16 Antecip Bioventures Ii Llc Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
US11730706B1 (en) 2022-07-07 2023-08-22 Antecip Bioventures Ii Llc Treatment of depression in certain patient populations
US11844797B1 (en) 2023-04-20 2023-12-19 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
US12194036B2 (en) 2022-07-07 2025-01-14 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
CN117224495A (zh) * 2023-11-03 2023-12-15 迪沙药业集团有限公司 一种盐酸安非他酮缓释制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337328B1 (en) * 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6306436B1 (en) * 2000-04-28 2001-10-23 Teva Pharmaceuticals Usa, Inc. Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
NZ544281A (en) * 2003-08-08 2008-07-31 Biovail Lab Int Srl Modified-release tablet of bupropion hydrochloride
WO2005065308A2 (en) * 2003-12-29 2005-07-21 Jason Mcdevitt Compositions and methods to treat recurrent medical conditions
US20060204571A1 (en) * 2005-03-12 2006-09-14 Sun Pharmaceutical Industries Limited Stable compositions of bupropion or its pharmaceutically acceptable salts
US7884136B2 (en) * 2005-06-27 2011-02-08 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
WO2008023390A2 (en) * 2006-08-21 2008-02-28 Jubilant Organosys Limited Modified release pharmaceutical composition of bupropion hydrochloride
WO2010004386A2 (en) * 2008-06-16 2010-01-14 Glenmark Generics Limited Amorphous bupropion hydrobromide and preparation thereof

Also Published As

Publication number Publication date
WO2009090670A3 (en) 2009-12-30
MX2010007672A (es) 2010-10-07
RU2010133982A (ru) 2012-02-27
WO2009090670A8 (en) 2009-09-11
ZA201004830B (en) 2011-03-30
US20100291225A1 (en) 2010-11-18
EP2229053A2 (en) 2010-09-22
CA2713365A1 (en) 2009-07-23
WO2009090670A2 (en) 2009-07-23
AU2008347949A1 (en) 2009-07-23
EP2229053A4 (en) 2011-01-12
KR20100107044A (ko) 2010-10-04

Similar Documents

Publication Publication Date Title
BRPI0819957A2 (pt) "composição farmacêutica estável e sustentada de hidrocloreto de bupropiona e processo para a preparação da mesma"
BRPI0908221A2 (pt) processo para preparar uma formulação farmacêutica de agentes de contraste
BRPI0818533A2 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0816991A2 (pt) Formulação, processo para preparar a mesma, e, usos de uma composição antimicrobiana e de uma formulação
BRPI0607423A2 (pt) forma microcristalina de um composto, processo para a preparação da mesma, uso de uma forma microcristalina, composição farmacêutica e processo para a preparação da mesma, e, produto
BRPI0914902A2 (pt) composição farmacêutica e método para tratamento de mal de parkinson
BRPI0910734A2 (pt) composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0807807A2 (pt) " composição farmacêutica de liberação modificada e um processo para fabricar a mesma ".
BRPI0905847A2 (pt) "composição farmacêutica injetável e processo para preparar a composição"
BRPI0717149A2 (pt) Composição oral contendo redes de gel e processo para o preparo da mesma
BRPI0924136A2 (pt) composição farmacêutica sólida compreendendo amlodipina e losartan e processo para a produção da mesma
BRPI0810763A2 (pt) Composição aglutinante betuminosa e processo para preparação da mesma
BRPI0814153A2 (pt) "método para preparar um composto e composto"
BRPI0812851A2 (pt) Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI0909691A2 (pt) Composto, método para preparar um composto, e, composição farmacêutica
BRPI0922714A2 (pt) composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica
BR122020011920A2 (pt) composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
BRPI0813644A2 (pt) Composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
BRPI0721883A2 (pt) Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma
BR112012016201A2 (pt) ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI0821354A2 (pt) Processo para a preparação de fipronil e de análogos do mesmo
BRPI0814163A2 (pt) Processo para a preparação de compostos, forma cristalina, e, composição farmacêutica
BRPI0811275A2 (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, uso de composto, e, método para tratar doença
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.